An interventional study of Redesigned immunization card and Center based education to mothers/caregivers in Childhood Immunization Completion, Childhood Immunization Dropout and Immunization Card, sponsored by University of Alabama at Birmingham. Completed at 1 site in Pakistan. Open to participants aged Up to 365 Days. Per ClinicalTrials.gov, last updated 2008-01-28.
Sponsored by University of Alabama at Birmingham · Not applicable, Interventional, and Supportive care
The objective of the study was to assess the effect of 1) redesigned immunization card, 2) center-based education to mothers, and 3) redesigned card with center-based education to mothers, provided at DPT1, on DPT3 completion in a randomized controlled trial at rural Expanded Programme on Immunization (EPI) centers in Karachi, Pakistan.
University of Alabama at Birmingham is the lead sponsor of 1,396 studies on the registry; 284 are open to participants now.
Of its 156 completed or terminated interventional studies of FDA-regulated products, 124 (79%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Redesigned immunization card
Other: Redesigned immunization card
Center based education to mothers/caregivers
Other: Center based education to mothers/caregivers
Redesigned immunization card with center based education to mothers/caregivers
Other: Redesigned immunization card with center based education to mother/caregivers
Standard care only
A low cost nad simplified redesigned immunization card
A 2-3 minute center based education to mothers/caregivers
Redesigned immunization card with center based education to mother/caregivers
The study outcome in each study group was the immunization status categorized into "DPT3 completed" and "DPT3 not completed".
Time frame: 90 day follow-up after enrollment at DPT1 visit
This study is completed, as verified in Jan 2008. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Alabama at Birmingham